US Broker Ratings

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring the 52% Upside Potential

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, is capturing investor attention with its potential for significant upside. Specializing in novel therapeutics..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: A Biotech Gem with 109% Potential Upside

Investors with an eye on the biotechnology sector might find Sarepta Therapeutics, Inc. (NASDAQ: SRPT) an intriguing opportunity, particularly given its substantial potential upside of 109.16%..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Exploring a 22% Potential Upside Amidst Healthcare Market Challenges

Bausch + Lomb Corporation (BLCO), a storied name in the healthcare sector, continues to navigate the complexities of the medical instruments and supplies industry. With roots..

Labcorp Holdings Inc. (LH) Stock Analysis: Navigating a 7.85% Potential Upside Amidst a Strong Buy Consensus

Labcorp Holdings Inc. (NYSE: LH) stands as a significant player in the healthcare sector, specifically within the Diagnostics & Research industry. With a robust market capitalization..

Charles River Laboratories (CRL) Stock Analysis: Evaluating Growth Potential Amidst Diagnostic Sector Challenges

Charles River Laboratories International, Inc. (NYSE: CRL) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Founded in 1947 and..

Haleon plc (HLN) Stock Analysis: Exploring Its 4.54% Potential Upside and Strategic Market Position

Haleon plc (HLN), a prominent player in the healthcare sector, has been making waves in the drug manufacturing industry with its impressive array of consumer healthcare..

Blueprint Medicines Corporation (BPMC) Stock Analysis: Navigating Biotech Growth with 55.5% Revenue Surge

Blueprint Medicines Corporation (NASDAQ: BPMC) stands out in the biotechnology sector, not just for its innovative approach to precision therapy, but also for its impressive 55.5%..

Guardant Health, Inc. (GH) Stock Analysis: Navigating a 23.67% Potential Upside in the Dynamic Diagnostics Sector

Guardant Health, Inc. (NASDAQ: GH) stands out as a pivotal player in the rapidly evolving field of precision oncology. With a market capitalization of $5.95 billion,..

BrightSpring Health Services (BTSG) Stock Analysis: Strong Buy Ratings and a 12.55% Upside Potential

BrightSpring Health Services, Inc. (NYSE: BTSG), a key player in the Health Information Services industry, has been catching the eye of investors with its robust buy..

Walgreens Boots Alliance (WBA) Stock Analysis: A Deep Dive into Healthcare Retail’s 8.89% Dividend Yield

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is a prominent player in the healthcare sector, specifically in pharmaceutical retailing. With its expansive presence across the United States..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 20.51% Upside with Strong Buy Ratings

For investors with an eye on the healthcare sector, Alcon Inc. (NYSE: ALC) presents a compelling opportunity. As a leading player in the medical instruments and..

Qiagen N.V. (QGEN) Stock Analysis: Exploring an 8.52% Potential Upside in the Healthcare Sector

Qiagen N.V. (NYSE: QGEN) stands as a prominent player in the diagnostics and research industry, offering a comprehensive suite of solutions that bridge biological samples to..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Strong Buy Ratings and 27% Potential Upside

Neurocrine Biosciences, Inc. (NBIX) stands out in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $12.41 billion,..

HCA Healthcare, Inc. (HCA) Stock Analysis: Navigating a Robust Market Cap with Impressive ROE

HCA Healthcare, Inc. (NYSE: HCA) stands out in the healthcare sector not only for its substantial market capitalization of $92.46 billion but also for its impressive..

Teleflex Incorporated (TFX) Stock Analysis: Potential 26.97% Upside in the Healthcare Sector

Teleflex Incorporated (NYSE: TFX) stands as a notable player in the healthcare sector, specializing in the design and supply of single-use medical devices. With a market..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring an 8.5% Upside in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector should consider Henry Schein, Inc. (NASDAQ: HSIC), a key player in medical distribution with a market capitalization of $8.8..

ADMA Biologics Inc (ADMA) Stock Analysis: Potential 43% Upside Amid Robust Revenue Growth

ADMA Biologics Inc (NASDAQ: ADMA) is capturing the attention of investors with its promising growth trajectory in the biotechnology sector. As a key player in the..

Option Care Health, Inc. (OPCH) Stock Analysis: A 20.86% Upside Awaits with Strong Buy Ratings

Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is capturing investor attention with its..

Incyte Corporation (INCY) Stock Analysis: A Biotech Powerhouse with a 7.44% Upside Potential

Incyte Corporation (NASDAQ: INCY) stands as a noteworthy player in the biotechnology sector, boasting a market capitalization of $13.31 billion. This Delaware-based biopharmaceutical company is renowned..

Bruker Corporation (BRKR) Investor Outlook: A 46% Upside Potential Amid Healthcare Innovation

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector and a specialist in medical devices, is drawing considerable attention from investors with a compelling..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds